Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 29377 | 187 | 16.1 | 39% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
| 3663 | 2 | BUCILLAMINE//AZECINES//LE300 | 1171 |
| 29377 | 1 | AZECINES//LE300//LEHRSTUHL PHARMAZEUT MED CHEM | 187 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | AZECINES | authKW | 1360757 | 5% | 83% | 10 |
| 2 | LE300 | authKW | 1306329 | 4% | 100% | 8 |
| 3 | LEHRSTUHL PHARMAZEUT MED CHEM | address | 1102193 | 10% | 38% | 18 |
| 4 | METHYL EPSILON HYDROXYCARBOXYLATES | authKW | 489874 | 2% | 100% | 3 |
| 5 | CARBOXYLIC ACIDS EPSILON HYDROXY | authKW | 326582 | 1% | 100% | 2 |
| 6 | ISOQUINO1 2 B3BENZAZEPINES | authKW | 326582 | 1% | 100% | 2 |
| 7 | EPSILON LACTONES | authKW | 217720 | 1% | 67% | 2 |
| 8 | 3 BENZAZECINE | authKW | 163291 | 1% | 100% | 1 |
| 9 | 3 BENZAZONINE | authKW | 163291 | 1% | 100% | 1 |
| 10 | ALPHA AMINOMETHYL GAMMA BUTYROLACTONES AND 3 AMINOMETHYLTETRAHYDROFURANS | authKW | 163291 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Medicinal | 4990 | 48% | 0% | 90 |
| 2 | Chemistry, Multidisciplinary | 1363 | 55% | 0% | 102 |
| 3 | Pharmacology & Pharmacy | 959 | 42% | 0% | 79 |
| 4 | Chemistry, Organic | 730 | 29% | 0% | 54 |
| 5 | Biochemical Research Methods | 5 | 3% | 0% | 5 |
| 6 | Crystallography | 2 | 2% | 0% | 3 |
| 7 | Chemistry, Analytical | 1 | 3% | 0% | 5 |
| 8 | Chemistry, Inorganic & Nuclear | -0 | 1% | 0% | 2 |
| 9 | Spectroscopy | -0 | 1% | 0% | 1 |
| 10 | Chemistry, Applied | -0 | 1% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | LEHRSTUHL PHARMAZEUT MED CHEM | 1102193 | 10% | 38% | 18 |
| 2 | CHEM TECHNOL FAK CENT NMR | 163291 | 1% | 100% | 1 |
| 3 | EX CHEM SCI | 163291 | 1% | 100% | 1 |
| 4 | LEHRSTUHL PHARMACEUT MED CHEM | 163291 | 1% | 100% | 1 |
| 5 | LEHTUHL PHARMAZEUT MED CHEM | 163291 | 1% | 100% | 1 |
| 6 | TEMPORARILY GENOM FONCT | 163291 | 1% | 100% | 1 |
| 7 | ABT MED CHEM | 81645 | 1% | 50% | 1 |
| 8 | GVC C | 81645 | 1% | 50% | 1 |
| 9 | PHARM PHARMAZEUT MED CHEM | 81645 | 1% | 50% | 1 |
| 10 | QUIM ORGAN UNIDAD ASOC | 81645 | 1% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ARCHIV DER PHARMAZIE | 141546 | 33% | 1% | 61 |
| 2 | LIEBIGS ANNALEN DER CHEMIE | 3247 | 4% | 0% | 8 |
| 3 | BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE PARTIE II-CHIMIE MOLECULAIRE ORGANIQUE ET BIOLOGIQUE | 2050 | 1% | 1% | 2 |
| 4 | HETEROCYCLES | 1775 | 6% | 0% | 12 |
| 5 | LIEBIGS ANNALEN | 1754 | 1% | 1% | 1 |
| 6 | PHARMAZIE | 1166 | 4% | 0% | 8 |
| 7 | ACTA POLONIAE PHARMACEUTICA | 1022 | 2% | 0% | 3 |
| 8 | LIEBIGS ANNALEN-RECUEIL | 775 | 1% | 0% | 2 |
| 9 | JOURNAL OF HETEROCYCLIC CHEMISTRY | 533 | 3% | 0% | 6 |
| 10 | ANNALES PHARMACEUTIQUES FRANCAISES | 496 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | ROBAA, D , ENZENSPERGER, C , ABULAZM, SE , HEFNAWY, MM , EL-SUBBAGH, HI , WANI, TA , LEHMANN, J , (2011) CHIRAL INDOLO[3,2-F][3]BENZAZECINE-TYPE DOPAMINE RECEPTOR ANTAGONISTS: SYNTHESIS AND ACTIVITY OF RACEMIC AND ENANTIOPURE DERIVATIVES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 54. ISSUE 20. P. 7422 -7426 | 9 | 75% | 11 |
| 2 | ROBAA, D , KRETSCHMER, R , SIOLI, O , ABULAZM, SE , ELKHAWASS, E , LEHMANN, J , ENZENSPERGER, C , (2011) RESIDUES AT THE INDOLE-NH OF LE300 MODULATE AFFINITIES AND SELECTIVITIES FOR DOPAMINE RECEPTORS.ARCHIV DER PHARMAZIE. VOL. 344. ISSUE 1. P. 28 -36 | 9 | 75% | 2 |
| 3 | HOEFGEN, B , DECKER, M , MOHR, P , SCHRAMM, AM , ROSTOM, SAF , EL-SUBBAGH, H , SCHWEIKERT, PM , RUDOLF, DR , KASSACK, MU , LEHMANN, J , (2006) DOPAMINE/SEROTONIN RECEPTOR LIGANDS. 10: SAR STUDIES ON AZECINE-TYPE DOPAMINE RECEPTOR LIGANDS BY FUNCTIONAL SCREENING AT HUMAN CLONED D-1, D-2L, AND D-5 RECEPTORS WITH A MICROPLATE READER BASED CALCIUM ASSAY LEAD TO A NOVEL POTENT D-1/D-5 SELECTIVE ANTAGONIST.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 49. ISSUE 2. P. 760 -769 | 9 | 75% | 46 |
| 4 | ENZENSPERGER, C , KILIAN, S , ACKERMANN, M , KOCH, A , KELCH, K , LEHMANN, J , (2007) DOPAMINE/SEROTONIN RECEPTOR LIGANDS. PART 15: OXYGENATION OF THE BENZ-INDOLO-AZECINE LE 300 LEADS TO NOVEL SUBNANOMOLAR DOPAMINE D-1/D-5 ANTAGONISTS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 17. ISSUE 5. P. 1399-1402 | 7 | 100% | 5 |
| 5 | ENZENSPERGER, C , LEHMANN, J , (2006) DOPAMINE/SEROTONIN RECEPTOR LIGANDS. 13: HOMOLOGIZATION OF A BENZINDOLOAZECINE-TYPE DOPAMINE RECEPTOR ANTAGONIST MODULATES THE AFFINITIES FOR DOPAMINE D-1-D-5 RECEPTORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 49. ISSUE 21. P. 6408 -6411 | 7 | 100% | 11 |
| 6 | WITTIG, TW , ENZENSPERGER, C , LEHMANN, J , (2003) DOPAMINE/SEROTONIN RECEPTOR LIGANDS VI. DIBENZ[G,J]-1-OXA-4-AZACYCLOUNDECENE AND DIBENZ[D,G]-2-AZACYCLOUNDECENE: SYNTHESIS OF TWO NEW HETEROCYCLIC RING SYSTEMS AS POTENTIAL LIGANDS FOR DOPAMINE RECEPTOR SUBTYPES.HETEROCYCLES. VOL. 60. ISSUE 4. P. 887 -898 | 6 | 100% | 5 |
| 7 | MEISE, W , ONUSSEIT, O , CLEMENS, M , (1999) SYNTHESIS OF ISOQUINO[1,2-ALPHA][2]BENZAZEPINES AND BIOCHEMICAL TESTING OF ISOMERIC HOMOBERBINES AND RELATED PAPAVERINE-DERIVATIVES ON THE INHIBITION OF PHOSPHODIESTERASES.PHARMAZIE. VOL. 54. ISSUE 9. P. 658-666 | 9 | 69% | 3 |
| 8 | MOHR, P , LEHMANN, J , DECKER, M , (2006) SYNTHESIS AND REACTIVITY OF DIBENZ[D,G]AZECIN-14(5H)-ONES.HETEROCYCLES. VOL. 68. ISSUE 5. P. 879 -884 | 5 | 100% | 0 |
| 9 | MEISE, W , ZLOTOS, D , JANSEN, M , ZOCHE, N , (1995) SYNTHESIS AND CONFORMATION OF HEXAHYDRO-ISOQUINO[3,2-A][2]BENZAZEPINES OF THE B-HOMOBERBINE TYPE.LIEBIGS ANNALEN-RECUEIL. VOL. . ISSUE 3. P. 567-574 | 7 | 100% | 5 |
| 10 | MEISE, W , ARTH, C , ZLOTOS, D , JANSEN, M , FELDMANN, C , (1994) SYNTHESIS AND CONFORMATION OF THE HEXAHYDRO-ISOQUINO[2,1-B][2]BENZAZEPINES.LIEBIGS ANNALEN DER CHEMIE. VOL. . ISSUE 11. P. 1135-1142 | 8 | 89% | 6 |
Classes with closest relation at Level 1 |